(CIX: WRAL30)  1,126.59  up arrow+2.55  (0.23 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: Apple)  111.78  down arrow-0.87  (-0.77 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: QUINTILES)  60.39  up arrow+1.01  (1.7 %)  Updated: 06:40 PM EST, Dec 19 2014
(OP: BASF SE)  85.15  down arrow-1.55  (-1.78 %)  Updated: 05:20 PM EST, Dec 19 2014
(NQ: BioCryst)  11.16  up arrow+0.08  (0.68 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: BioDelivery)  13.82  up arrow+0.76  (5.82 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: CEMP)  21.31  up arrow+0.8  (3.9 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: Cisco Systems)  27.77  up arrow+0.12  (0.43 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: Cree)  31.21  up arrow+0.31  (1 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: DARA)  0.88  up arrow+0.04  (4.3 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: EMC CORPORATION)  30.14  up arrow+0.19  (0.63 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: Extreme Networks)  3.44  up arrow+0.09  (2.69 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: FB)  79.88  up arrow+1.48  (1.89 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: GLAXOSMITHKLINE)  43.35  up arrow+0.06  (0.14 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: GOOG)  516.35  up arrow+5.25  (1.03 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: IBM)  158.51  up arrow+0.83  (0.53 %)  Updated: 06:40 PM EST, Dec 19 2014
(NY: LH)  105.80  down arrow-0.64  (-0.6 %)  Updated: 06:40 PM EST, Dec 19 2014
(OP: Lenovo Group)  26.38  up arrow+0.82  (3.21 %)  Updated: 05:20 PM EST, Dec 19 2014
(NY: MRK)  59.58  up arrow+0.6  (1.02 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: Microsoft Corp)  47.66  up arrow+0.14  (0.29 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: NTAP)  42.94  up arrow+0.22  (0.52 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: NOVARTIS AG)  94.61  up arrow+0.04  (0.04 %)  Updated: 06:40 PM EST, Dec 19 2014
(OP: Novozymes A/S)  43.11  down arrow-0.32  (-0.73 %)  Updated: 05:20 PM EST, Dec 19 2014
(NY: PFIZER)  31.94  down arrow-0.03  (-0.09 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: Pozen)  8.17  up arrow+0.27  (3.42 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: RED HAT)  68.04  up arrow+6.54  (10.63 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: BBRY)  9.99  down arrow-0.08  (-0.79 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: Salix)  117.20  down arrow-1.25  (-1.06 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: SQI)  14.97  down arrow-0.09  (-0.6 %)  Updated: 08:10 PM EST, Dec 19 2014

Posts tagged “Emory”

July 26, 2013

Premium Lock RTP biotech veteran Painter to 'DRIVE' Emory pharma R&D

DNA George Painter brings 30 years experience to Emory University. In other regional life science news, Wake Forest Innovations finds a partner for health mobile apps development and Cornerstone Therapeutics sues a rival for patent infringement.

June 12, 2013

Premium Lock Emory bridges pharma 'valley of death' by launching new company

Biotech & Life Science Aiming to combine university lab resources with industry leadership, Emory announced it is launching Drug Innovation Ventures at Emory, or DRIVE, a not-for-profit company that is separate from the Emory but still owned by the university.

November 15, 2012

Premium Lock UNC, Duke, Wake Forest to offer undergraduate courses online

UNC-Chapel Hill, Duke and Wake Forest are teaming up with several other universities to offer online undergraduate courses for credit and that can be taken at a member university where a student isn't enrolled.

UNC, Duke, Wake Forest join Semester Online UNC, Duke, Wake Forest join Semester Online

February 21, 2012

Premium Lock Vision firm with R&D office in Durham closing on $4M investment

Hatteras Venture Partners is backing Georgia-based Clearside Biomedical which is developing a drug delivery platform for eye medications.

Clearside targets eye health Clearside targets eye health

February 1, 2012

Premium Lock Atlanta firm looks to raise $6M for image-guided surgical device

STATE OF VENTURE: Spectropath's imaging technology was developed at Emory University and the Georgia Institute of Technology, and spun into a company in 2010. Spectropath has already raised about $417,000 in its first round of funding.

Spectropath Spectropath

February 2, 2011

Premium Lock Duke's Fuqua School climbs in Financial Times Global 100

Fuqua School at Duke UNC-CH, Emory and South Carolina slip in rankings; Wake Forest cracks the list.

December 14, 2010

Premium Lock RTI-led consortium is one of 3 preferred providers in CDC contract

RTI International Duke, UNC-Ch and Emory are part of the group that can compete for projects to assist health care in emerging nations.

Updated May 10, 2010

Premium Lock Study: Growing number of cancer patients double treatment costs

Cancer patients, costs groq Many more people afflicted with cancer also now receive outpatient care. Researchers at RTI International, Emory University and CDC report that costs increased to $48.1 billion in 2005 from inflation-adjusted total of $24.7 billion in 1987.

Updated January 20, 2010

Premium Lock GSK plans 'Open Lab' for campaign to defeat malaria, picks Emory as partner

The drug giant will allow outside scientists to access its data and also broaden efforts to combat other maladies through its recently announced patent pool, CEO Andrew Witty says. Emory University's Institute for Drug Discovery will be a partner.

A Malaria victim in Cambodia. (AP) A Malaria victim in Cambodia. (AP)

June 25, 2009

Premium Lock Georgia Tech launches center to help improve recovery of severely injured soldiers

Bridging bones UniversityTech: Musculoskeletal biology and regenerative medicine expertise are keys to effort, Tech says.

May 18, 2009

Premium Lock Emory University tech transfer exec takes over as SEBIO leader

 Jennifer Moore replaces Stephanie Adams at 10-year-old life sickness organization.

May 5, 2009

Premium Lock Gates’ ‘Grand Challenge’ grants fund Duke, Emory projects

Gates Foundation funds global research Duke scientist pursues eradication of malaria; Emory project focuses on possible vaccine for tuberculosis.

Updated April 14, 2009

Premium Lock Dreaming: What if Cisco invested $2B at home rather than South Korea?

John Chambers John Chambers commits to huge investment in R&D, financing and venture funds in his play for more Asia business. Korea's president thanks him for a 'difficult decision.'

Updated December 11, 2008

Premium Lock Five N.C. firms add 'fellows' through Biotech Center program

Five North Carolina companies are each gaining a research scientist – at no cost – as part of the new “Industrial Fellowships Program” funded by the North Carolina Biotechnology Center.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith


Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa